Skip to main content


Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 3/2013

Ausgabe 3/2013

Inhaltsverzeichnis ( 21 Artikel )

01.12.2013 | Review | Ausgabe 3/2013

Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998–2002

Katharine Yao, David J. Winchester, Tomasz Czechura, Dezheng Huo

01.12.2013 | Preclinical Study | Ausgabe 3/2013

DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells

Johanna Tuomela, Jouko Sandholm, Mika Kaakinen, Ankita Patel, Joonas H. Kauppila, Joanna Ilvesaro, Dongquan Chen, Kevin W. Harris, David Graves, Katri S. Selander

01.12.2013 | Preclinical Study | Ausgabe 3/2013

Role of HGF in obesity-associated tumorigenesis: C3(1)-TAg mice as a model for human basal-like breast cancer

Sneha Sundaram, Alex J. Freemerman, Amy R. Johnson, J. Justin Milner, Kirk K. McNaughton, Joseph A. Galanko, Katharine M. Bendt, David B. Darr, Charles M. Perou, Melissa A. Troester, Liza Makowski

01.12.2013 | Preclinical study | Ausgabe 3/2013

A relative ordering-based predictor for tamoxifen-treated estrogen receptor-positive breast cancer patients: multi-laboratory cohort validation

Xianxiao Zhou, Bailiang Li, Yuannv Zhang, Yunyan Gu, Beibei Chen, Tongwei Shi, Lu Ao, Pengfei Li, Shan Li, Chunyang Liu, Zheng Guo

01.12.2013 | Preclinical study | Ausgabe 3/2013

Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy

Tarek M. A. Abdel-Fatah, Nada Albarakati, Lara Bowell, Devika Agarwal, Paul Moseley, Claire Hawkes, Graham Ball, Stephen Chan, Ian O. Ellis, Srinivasan Madhusudan

01.12.2013 | Preclinical Study | Ausgabe 3/2013

Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer

Kristina P. Sørensen, Mads Thomassen, Qihua Tan, Martin Bak, Søren Cold, Mark Burton, Martin J. Larsen, Torben A. Kruse

01.12.2013 | Preclinical study | Ausgabe 3/2013

Tamoxifen selects for breast cancer cells with mammosphere forming capacity and increased growth rate

Diego Raffo, Damian E. Berardi, Osvaldo Pontiggia, Laura Todaro, Elisa Bal de Kier Joffé, Marina Simian

01.12.2013 | Clinical trial | Ausgabe 3/2013

Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer

Xiaosong Chen, Guolin Ye, Chenfang Zhang, Xinzheng Li, Yiding Chen, Xiaohong Xie, Hong Zheng, Yali Cao, Kejin Wu, Duo Ni, Jinhai Tang, Ziguo Wei, Kunwei Shen

01.12.2013 | Clinical trial | Ausgabe 3/2013

Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients

Kyung Lan Ko, In Suk Shin, Ji Young You, So-Youn Jung, Jungsil Ro, Eun Sook Lee

01.12.2013 | Clinical trial | Ausgabe 3/2013

Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide

Harriet Johansson, Bernardo Bonanni, Sara Gandini, Aliana Guerrieri-Gonzaga, Massimiliano Cazzaniga, Davide Serrano, Debora Macis, Antonella Puccio, Maria Teresa Sandri, Marcella Gulisano, Franca Formelli, Andrea DeCensi

01.12.2013 | Clinical trial | Ausgabe 3/2013

Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients

R. Wolters, A. Wöckel, W. Janni, I. Novopashenny, F. Ebner, R. Kreienberg, M. Wischnewsky, L. Schwentner, For the BRENDA Study Group

01.12.2013 | Clinical Trial | Ausgabe 3/2013

Radiotherapy in implant-based immediate breast reconstruction: risk factors, surgical outcomes, and patient-reported outcome measures in a large Swedish multicenter cohort

Max Eriksson, Lotta Anveden, Fuat Celebioglu, Kristina Dahlberg, Ingrid Meldahl, Jakob Lagergren, Catharina Eriksen, Jana de Boniface

01.12.2013 | Epidemiology | Ausgabe 3/2013 Open Access

Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer

Sara A. Hurvitz, Deepa Lalla, Ross D. Crosby, Susan D. Mathias

01.12.2013 | Epidemiology | Ausgabe 3/2013

Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral

Sarah L. Ingham, Matthew Sperrin, Andrew Baildam, Gary L. Ross, Richard Clayton, Fiona Lalloo, Iain Buchan, Anthony Howell, D. Gareth R. Evans

01.12.2013 | Epidemiology | Ausgabe 3/2013

Promoter methylation of BRCA1 in the prognosis of breast cancer: a meta-analysis

Liang Wu, Fengliang Wang, Ruobing Xu, Simin Zhang, Xianzhen Peng, Yan Feng, Jianming Wang, Cheng Lu

01.12.2013 | Epidemiology | Ausgabe 3/2013

Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors

Henry G. Kaplan, Judith A. Malmgren, Christopher I. Li, Gregory S. Calip

01.12.2013 | Epidemiology | Ausgabe 3/2013

Risk of GWAS-identified genetic variants for breast cancer in a Chinese population: a multiple interaction analysis

Wei Chen, Haiping Song, Rong Zhong, Beibei Zhu, Hui Guo, Jiao Lou, Na Shen, Jiaoyuan Li, Xueqin Chen, Cheng Liu, Jie Ming, Tao Huang, Xiaoping Miao

01.12.2013 | Brief Report | Ausgabe 3/2013

Cardiovascular disease among breast cancer survivors: the call for a clinical vascular health toolbox

Lynnette M. Jones, Lee Stoner, Casey Brown, Chris Baldi, Blair McLaren

01.12.2013 | Brief Report | Ausgabe 3/2013

Addition of bevacizumab to three docetaxel regimens as adjuvant therapy for early stage breast cancer

Denise A. Yardley, Lowell Hart, David Waterhouse, Robert Whorf, D. Randolph Drosick, Patrick Murphy, Suprith Badarinath, Brooke R. Daniel, Barrett H. Childs, Howard Burris

01.12.2013 | Brief Report | Ausgabe 3/2013

Assessing racial/ethnic disparities in chemotherapy treatment among breast cancer patients in context of changing treatment guidelines

Abigail Silva, Garth H. Rauscher, Kent Hoskins, Ruta Rao, Carol Estwing Ferrans

01.12.2013 | Ausgabe 3/2013

Acknowledgement of reviewers 2013

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.